INSTRUCTION TO AUTHORS
Instruction to Authors
Journal of Pharmaceutical Science and Bioscientific Research is an international open access journal that
publishes innovative papers, reviews, rapid communications and notes dealing with field of Pharmacy and
Pharmaceutical Science. Areas of particular interest include: Pharmaceutical Technology, Novel Drug Delivery,
Biopharmaceutics, Pharmacokinetics, Pharmaceutical Analysis, Medicinal Chemistry, Clinical and Hospital
Pharmacy, Pharmacognosy and Phytochemistry, Pharmacology, Bioinformatics and Biotechnology, Cell Biology,
Genomic and Proteomics, Genetics Quality Assurance and Pharmaceutical Regulatory Affairs, Pharmaceutical
Regulatory Affairs, Pharmaceutical Regulatory Affairs and Pharma Management of Pharmaceutical Interest.
Before You Begin:
All submitted manuscripts should contain original work neither published previously not under consideration for
publication elsewhere. Articles from any part of the world are accepted provided submitted in English language
only. Page limit for Research article and for Review article is 15-20 pages. Authors, in their cover letter to Editor,
should clearly mention whether the manuscript is to be considered as a Research or a Review article. In case of
Review article, should include current topics on the subject of general interest.
It is necessary that authors prepare their manuscripts according to the instructions. Effectiveness of the peer
review process will greatly depends upon the care used by the authors in preparing the manuscripts.
Authors must state in a covering letter when submitting papers for publication the novelty embodied in
their work or in the approach taken in their research.
Cover letter sample is given at web site www.jpsbr.org If any query arises please contact
at email@example.com or at website www.jpsbr.org
Peer Review Process:
All manuscripts receive individual identification codes. The Editor in Chief then sends it to a proper editor. The
editors are fully responsible for decisions about manuscripts. The final decision whether to accept or to reject
manuscript rests with editors. Editor in Chief only communicates the final decision and informs about the further
Revised Manuscript Submission:
Whenever revision of a manuscript is needed, authors should return the revised version of their manuscripts as
early as possible. This will help them for rapid processing for further.
Transfer of Copy right Agreement:
Transfer of Copyright Agreement must be provided for each accepted manuscript and that should be dully signed,
scanned and sent via mail to the Editor in Chief. Download the copyright form from Here PDF
Formats of manuscript
The following sections are required and should be arranged in the following order: Cover Letter, Manuscript
[Title page, Abstract, Keywords, 1. Introduction, 2. Materials and methods, 3. Results and discussion, 4.
Conclusion, (Acknowledgements), References, Figure and Table with legends].
Prepare Manuscript in Calibri font using font size of 12 with normal margins on all the sides. Title shall be in a font
size 14, bold face capitals. All section titles shall be in font size 12, bold face capitals. Pages should be numbered
consecutively. Subtitles in every section shall be in font size 12, bold face lower case. Standard International
Units should be used through the text.
Manuscripts should be submitted as per order: Title Page, Abstract, Key words, Introduction, Material and
Methods, Results, Discussion and References.
The title should be as short as possible and precisely indicate the nature of the work in the communication.
Names of the authors should appear as initials followed by surnames along with their affiliation. At the bottom left
corner of the title page, please mention “*For Correspondence” and provide a functional e-mail address of
corresponding author only. If any of the co-authors are from different organizations, their addresses also be
mentioned and indicated using numbers after their names.
Should be started on new page after the title page and it should not exceed 250 words. The Abstract should be
informative and should state briefly the purpose of the research, the principal results and major conclusions.
Key words: 5-7 key words must be given at the end of the abstract.
Should starts on new page. This part should define the background and significance of the study by considering
the relevant literature, particularly the most recent publications.
Materials and Methods
Please provide concise but complete information about the material and the analytical, statistical and
experimental procedures used. This part should be as clear to enable other scientists to repeat the research
Results and Discussions
All findings presented in tabular or graphical form shall be described in this section. The data should be
statistically analysed and the level of significance stated. Data that is not statistically significant need only to be
mentioned in the text - no illustration is necessary. All Tables and figures must have a title or caption and a legend
to make them self-explanatory.
Discussion must be written with reference to the tables and figures and by considering information from the
literature and should contain a short review of the results. Any Statements made in the any above sections should
not be repeated here. There is no restriction for result and discussion to be written separately.
Should be numbered consecutively in the order in which they are first mentioned in the text (not in alphabetic
order). Identify references in text, tables and legends by Arabic numerals in superscript in square brackets.
References cited only in tables or figure legends should be numbered in accordance with the sequence
established by the first identification in the text of the particular table or figure.
Journals: Shah NM, Fransis R and Lesaly RJ. Synthesis Characterization and Analytical Studies of Adosupine,
Journal of Pharmacy Science, 2008; 134(5):1448-58.
Book: Shah Mamta and Marfatia Sangeeta. A Text Book of Pharmacognosy, Nirav & Roopal Publication,
Ahmedabad, First Edition. 2011:65-68.
Thesis: Kaplan SJ. Posthospital Home Health Care: The Elderly's Access and Utilization [dissertation]. St. Louis
Washington University. 1995: 78-80.
Patent: Kulkarni N, Kumar LD and Sorg A. Fast Dissolving Orally Consumable Films containing an Antitussive
and a Mucosa Coating Agent, U.S. Patent 2003/206942, Nov 6, 2003.
Website: Cartwright J (2007) Big stars have weather too. IOP Publishing Physics Web
(http://physicsweb.org/Articles/news/11/6/16/1). Accessed 26 June 2015.
Tables and figures
Tables: Each table must be given on a separate page with a brief but complete and self explanatory caption so
that the reader can easily understand the results presented in the table. Please do not duplicate material that is
already presented in the figures.
Figures: Photos or drawings must have a good contrast of dark and light. Legends of figures should be brief, but
complete and self- explanatory so that the reader can easily understand the results presented in the figure.
Please do not duplicate material that is already presented in the tables.
Authors using experimental animals and human subjects in their investigation must seek approval from the
appropriate Ethical Committee. The method section must include a statement to prove that the investigation was
approved and that informed consent was obtained. Authors have to submit scan copy of their Approval Certificate
as an attachment via firstname.lastname@example.org and in cover note they have to mention their protocol number.
Copyright © 2014 JPSBR Publications
Powered by Opus